The value of cerebrospinal fluid α‐synuclein and the tau/α‐synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology

Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease

(2018) Min Shi et al.   Alzheimers & Dementia

α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies

(2018) Inger van Steenoven et al.   MOVEMENT DISORDERS

Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study

(2017) Manuel Delgado-Alvarado et al.   MOVEMENT DISORDERS

A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations

(2017) Brit Mollenhauer et al.   MOVEMENT DISORDERS

Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis

(2017) Paolo Eusebi et al.   MOVEMENT DISORDERS

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

(2017) Davide Chiasserini et al.   Alzheimers Research & Therapy

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

(2016) Anja Hviid Simonsen et al.   Biomarkers in Medicine

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

(2016) Franc Llorens et al.   JOURNAL OF NEUROLOGY

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

(2016) Nour K. Majbour et al.   Molecular Neurodegeneration

Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders

(2015) Zheng-Yu Wang et al.   INTERNATIONAL PSYCHOGERIATRICS

Alpha-synuclein and tau: teammates in neurodegeneration?

(2014) Simon Moussaud et al.   Molecular Neurodegeneration

CSF A 42 predicts early-onset dementia in Parkinson disease

(2014) G. Alves et al.   NEUROLOGY

The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies – A systematic review and meta-analysis

(2013) Xuxin Lim et al.   PARKINSONISM & RELATED DISORDERS

Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy

(2013) Malin Wennström et al.   PLoS One

Clinical and multimodal biomarker correlates of ADNI neuropathological findings

(2013) Jon B Toledo et al.   Acta Neuropathologica Communications

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

(2011) Lucilla Parnetti et al.   MOVEMENT DISORDERS

Interaction between -Synuclein and Other Proteins in Neurodegenerative Disorders

(2011) Kurt A. Jellinger   TheScientificWorldJOURNAL

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

(2009) G Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Frequency and Case Identification of Dementia with Lewy Bodies Using the Revised Consensus Criteria

(2008) Dag Aarsland et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?

(2008) Annika Öhrfelt et al.   NEUROSCIENCE LETTERS